IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma (Q50042435)
Jump to navigation
Jump to search
scientific article published on 13 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma |
scientific article published on 13 November 2017 |
Statements
1 reference
IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma (English)
1 reference
Thomas M Cardillo
1 reference
Serengulam V Govindan
1 reference
Maria B Zalath
1 reference
Diane L Rossi
1 reference
Yang Wang
1 reference
Chien-Hsing Chang
1 reference
David M Goldenberg
1 reference
13 November 2017
1 reference
17
1 reference
1
1 reference
150-160
1 reference